Avidity Biosciences, Inc. (RNAM)
NASDAQ: RNAM · Real-Time Price · USD
72.82
+0.02 (0.03%)
At close: Feb 26, 2026

Avidity Biosciences Revenue

In the year 2025, Avidity Biosciences had annual revenue of $18.76M with 72.11% growth. Avidity Biosciences had revenue of $860.00K in the quarter ending December 31, 2025, a decrease of -71.07%.

Revenue (ttm)
$18.76M
Revenue Growth
+72.11%
P/S Ratio
602.40
Revenue / Employee
$36,703
Employees
511
Market Cap
11.30B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202518.76M7.86M72.11%
Dec 31, 202410.90M1.34M13.99%
Dec 31, 20239.56M336.00K3.64%
Dec 31, 20229.22M-102.00K-1.09%
Dec 31, 20219.33M2.54M37.41%
Dec 31, 20206.79M4.47M192.67%
Dec 31, 20192.32M1.94M511.87%
Dec 31, 2018379.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition